US Stock MarketDetailed Quotes

GLSI Greenwich LifeSciences

Watchlist
  • 14.320
  • -0.900-5.91%
Close Sep 26 16:00 ET
  • 14.340
  • +0.020+0.14%
Post 20:02 ET
188.23MMarket Cap-18126P/E (TTM)

Greenwich LifeSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-33.98%7.22M
-53.77%5.51M
-48.10%6.99M
-48.10%6.99M
-41.53%9.14M
-36.33%10.94M
-39.67%11.91M
-50.49%13.47M
-50.49%13.47M
-45.90%15.64M
-Cash and cash equivalents
-33.98%7.22M
-53.77%5.51M
-48.10%6.99M
-48.10%6.99M
-41.53%9.14M
-36.33%10.94M
-39.67%11.91M
-50.49%13.47M
-50.49%13.47M
-45.90%15.64M
Other current assets
--3.59K
----
----
----
----
----
----
----
----
----
Total current assets
-33.95%7.23M
-53.77%5.51M
-48.10%6.99M
-48.10%6.99M
-41.53%9.14M
-36.33%10.94M
-39.67%11.91M
-50.49%13.47M
-50.49%13.47M
-45.90%15.64M
Non current assets
Goodwill and other intangible assets
----
-44.59%4.49K
-40.12%5.39K
-40.12%5.39K
-36.46%6.29K
-33.42%7.2K
-30.84%8.1K
-28.63%9K
-28.63%9K
-26.72%9.91K
-Other intangible assets
----
-44.59%4.49K
-40.12%5.39K
-40.12%5.39K
-36.46%6.29K
-33.42%7.2K
-30.84%8.1K
-28.63%9K
-28.63%9K
-26.72%9.91K
Total non current assets
--0
-44.59%4.49K
-40.12%5.39K
-40.12%5.39K
-36.46%6.29K
-33.42%7.2K
-30.84%8.1K
-28.63%9K
-28.63%9K
-26.72%9.91K
Total assets
-34.00%7.23M
-53.77%5.51M
-48.10%6.99M
-48.10%6.99M
-41.53%9.15M
-36.32%10.95M
-39.66%11.92M
-50.48%13.48M
-50.48%13.48M
-45.89%15.65M
Liabilities
Current liabilities
Payables
1,577.05%1.34M
56.93%346.58K
16.06%256.32K
16.06%256.32K
4.55%230.9K
--79.62K
--220.85K
0.00%220.85K
0.00%220.85K
--220.85K
-accounts payable
1,577.05%1.34M
56.93%346.58K
16.06%256.32K
16.06%256.32K
4.55%230.9K
--79.62K
--220.85K
0.00%220.85K
0.00%220.85K
--220.85K
Current accrued expenses
-91.98%17.8K
192.12%43.03K
-9.44%38.09K
-9.44%38.09K
289.72%66.39K
-3.14%221.93K
-93.89%14.73K
-74.40%42.06K
-74.40%42.06K
-96.26%17.03K
Current liabilities
348.70%1.35M
65.39%389.61K
11.98%294.41K
11.98%294.41K
24.97%297.29K
31.60%301.55K
-2.32%235.58K
-31.74%262.91K
-31.74%262.91K
-47.73%237.88K
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
348.70%1.35M
65.39%389.61K
11.98%294.41K
11.98%294.41K
24.97%297.29K
31.60%301.55K
-2.32%235.58K
-31.74%262.91K
-31.74%262.91K
-47.73%237.88K
Shareholders'equity
Share capital
1.71%13.07K
0.22%12.88K
0.00%12.85K
0.00%12.85K
0.00%12.85K
0.57%12.85K
-0.80%12.85K
-2.28%12.85K
-2.28%12.85K
-1.12%12.85K
-common stock
1.71%13.07K
0.22%12.88K
0.00%12.85K
0.00%12.85K
0.00%12.85K
0.57%12.85K
-0.80%12.85K
-2.28%12.85K
-2.28%12.85K
-1.12%12.85K
Retained earnings
-22.59%-55.44M
-21.19%-52.84M
-21.44%-50.36M
-21.44%-50.36M
-23.10%-47.62M
-24.37%-45.23M
-22.41%-43.6M
-23.26%-41.47M
-23.26%-41.47M
-23.64%-38.68M
Paid-in capital
9.74%61.31M
4.84%57.95M
4.35%57.05M
4.35%57.05M
4.40%56.46M
4.77%55.86M
0.27%55.27M
-9.58%54.67M
-9.58%54.67M
-9.47%54.08M
Total stockholders'equity
-44.83%5.88M
-56.17%5.12M
-49.29%6.7M
-49.29%6.7M
-42.55%8.85M
-37.24%10.65M
-40.13%11.68M
-50.75%13.21M
-50.75%13.21M
-45.86%15.41M
Total equity
-44.83%5.88M
-56.17%5.12M
-49.29%6.7M
-49.29%6.7M
-42.55%8.85M
-37.24%10.65M
-40.13%11.68M
-50.75%13.21M
-50.75%13.21M
-45.86%15.41M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -33.98%7.22M-53.77%5.51M-48.10%6.99M-48.10%6.99M-41.53%9.14M-36.33%10.94M-39.67%11.91M-50.49%13.47M-50.49%13.47M-45.90%15.64M
-Cash and cash equivalents -33.98%7.22M-53.77%5.51M-48.10%6.99M-48.10%6.99M-41.53%9.14M-36.33%10.94M-39.67%11.91M-50.49%13.47M-50.49%13.47M-45.90%15.64M
Other current assets --3.59K------------------------------------
Total current assets -33.95%7.23M-53.77%5.51M-48.10%6.99M-48.10%6.99M-41.53%9.14M-36.33%10.94M-39.67%11.91M-50.49%13.47M-50.49%13.47M-45.90%15.64M
Non current assets
Goodwill and other intangible assets -----44.59%4.49K-40.12%5.39K-40.12%5.39K-36.46%6.29K-33.42%7.2K-30.84%8.1K-28.63%9K-28.63%9K-26.72%9.91K
-Other intangible assets -----44.59%4.49K-40.12%5.39K-40.12%5.39K-36.46%6.29K-33.42%7.2K-30.84%8.1K-28.63%9K-28.63%9K-26.72%9.91K
Total non current assets --0-44.59%4.49K-40.12%5.39K-40.12%5.39K-36.46%6.29K-33.42%7.2K-30.84%8.1K-28.63%9K-28.63%9K-26.72%9.91K
Total assets -34.00%7.23M-53.77%5.51M-48.10%6.99M-48.10%6.99M-41.53%9.15M-36.32%10.95M-39.66%11.92M-50.48%13.48M-50.48%13.48M-45.89%15.65M
Liabilities
Current liabilities
Payables 1,577.05%1.34M56.93%346.58K16.06%256.32K16.06%256.32K4.55%230.9K--79.62K--220.85K0.00%220.85K0.00%220.85K--220.85K
-accounts payable 1,577.05%1.34M56.93%346.58K16.06%256.32K16.06%256.32K4.55%230.9K--79.62K--220.85K0.00%220.85K0.00%220.85K--220.85K
Current accrued expenses -91.98%17.8K192.12%43.03K-9.44%38.09K-9.44%38.09K289.72%66.39K-3.14%221.93K-93.89%14.73K-74.40%42.06K-74.40%42.06K-96.26%17.03K
Current liabilities 348.70%1.35M65.39%389.61K11.98%294.41K11.98%294.41K24.97%297.29K31.60%301.55K-2.32%235.58K-31.74%262.91K-31.74%262.91K-47.73%237.88K
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 348.70%1.35M65.39%389.61K11.98%294.41K11.98%294.41K24.97%297.29K31.60%301.55K-2.32%235.58K-31.74%262.91K-31.74%262.91K-47.73%237.88K
Shareholders'equity
Share capital 1.71%13.07K0.22%12.88K0.00%12.85K0.00%12.85K0.00%12.85K0.57%12.85K-0.80%12.85K-2.28%12.85K-2.28%12.85K-1.12%12.85K
-common stock 1.71%13.07K0.22%12.88K0.00%12.85K0.00%12.85K0.00%12.85K0.57%12.85K-0.80%12.85K-2.28%12.85K-2.28%12.85K-1.12%12.85K
Retained earnings -22.59%-55.44M-21.19%-52.84M-21.44%-50.36M-21.44%-50.36M-23.10%-47.62M-24.37%-45.23M-22.41%-43.6M-23.26%-41.47M-23.26%-41.47M-23.64%-38.68M
Paid-in capital 9.74%61.31M4.84%57.95M4.35%57.05M4.35%57.05M4.40%56.46M4.77%55.86M0.27%55.27M-9.58%54.67M-9.58%54.67M-9.47%54.08M
Total stockholders'equity -44.83%5.88M-56.17%5.12M-49.29%6.7M-49.29%6.7M-42.55%8.85M-37.24%10.65M-40.13%11.68M-50.75%13.21M-50.75%13.21M-45.86%15.41M
Total equity -44.83%5.88M-56.17%5.12M-49.29%6.7M-49.29%6.7M-42.55%8.85M-37.24%10.65M-40.13%11.68M-50.75%13.21M-50.75%13.21M-45.86%15.41M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data